Wnt5a expression correlates significantly with malignancy and stage of progression in malignant melanoma [5, 6], gastric cancer [7–9], prostate cancer [10], lung cancer [11], and pancreatic cancer [12]. Here, WNT5A is linked to gastric cancer.